Fox Chase Cancer Center Welcomes Dr. Abigail T. Berman

Dr. Berman
Fox Chase is pleased to announce the hiring of Abigail T. Berman, MD, MSCE, as an assistant professor in the Department of Radiation Oncology.

PHILADELPHIA (May 2, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Abigail T. Berman, MD, MSCE, as an assistant professor in the Department of Radiation Oncology. Berman will focus on caring for patients with thoracic and gastrointestinal cancers.

Most recently, Berman served as a radiation oncologist at Penn Medicine and currently serves as Head of Enterprise Radiation Oncology at CVS Health. During her time as assistant professor of Radiation Oncology at Penn Medicine, she held a number of other roles, including associate director at the Penn Center for Precision Medicine and residency program director in radiation oncology.

Berman earned her undergraduate degree in chemistry from Harvard University and her medical degree from the University of Pennsylvania Perelman School of Medicine, where she also received a Master of Science in Clinical Epidemiology. She completed her residency in radiation oncology at the Hospital of the University of Pennsylvania.

She is a member of the American Society for Radiation Oncology, the American Society for Clinical Oncology, and the American Association for Cancer Education. Over the course of her career, Berman has earned multiple honors recognizing her abilities as an academic, including the ARRO Educator of the Year Award. She has also published over 100 peer-reviewed journal articles and book chapters and has lectured on radiation oncology nationally and internationally.

Berman began her tenure at Fox Chase on March 13.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427